Your browser doesn't support javascript.
loading
Metabolic associated fatty liver disease and cardiovascular risk: The expert opinion of the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society.
Gorczyca-Glowacka, Iwona; Welnicki, Marcin; Mamcarz, Artur; Filipiak, Krzysztof J; Wozakowska-Kaplon, Beata; Barylski, Marcin; Szymanski, Filip M; Kasprzak, Jaroslaw D; Tomasiewcz, Krzysztof.
Afiliação
  • Gorczyca-Glowacka I; Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland. iwona.gorczyca@interia.pl.
  • Welnicki M; 3rd Department of Internal Diseases and Cardiology, Warsaw Medical University, Warszawa, Poland.
  • Mamcarz A; 3rd Department of Internal Diseases and Cardiology, Warsaw Medical University, Warszawa, Poland.
  • Filipiak KJ; Institute of Clinical Sciences, Maria Sklodowska-Curie Medical Academy in Warsaw, Warszawa, Poland.
  • Wozakowska-Kaplon B; Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland.
  • Barylski M; 1st Department of Cardiology and Electrotherapy, Swietokrzyskie Cardiology Center in Kielce, Kielce, Poland.
  • Szymanski FM; Department of Internal Diseases and Cardiological Physiotherapy, Medical University in Lodz, Lódz, Poland.
  • Kasprzak JD; Department of Civilization Diseases, Collegium Medicum, Cardinal Stefan Wyszynski University in Warsaw, Warszawa, Poland.
  • Tomasiewcz K; 1st Department of Cardiology, Medical University in Lodz, Lódz, Poland.
Kardiol Pol ; 81(2): 207-214, 2023.
Article em En | MEDLINE | ID: mdl-36866400
ABSTRACT
The diagnosis of metabolic associated fatty liver disease (MAFLD) is significant for patients' prognosis, as the disease accelerates the development of cardiovascular complications and, on the other hand, cardiometabolic conditions are risk factors for the development of fatty liver diseases. This expert opinion presents principles of MAFLD diagnosis and standards of management to reduce cardiovascular risks in patients with MAFLD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hepatopatias Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Kardiol Pol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Hepatopatias Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Kardiol Pol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia